According to Viatris's latest financial reports the company has $1.18 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | $1.18 B | -19.57% |
2022-12-31 | $1.47 B | 57.49% |
2021-12-31 | $0.93 B | -10.77% |
2020-12-31 | $1.04 B | 79.22% |
2019-12-31 | $0.58 B | 21.96% |
2018-12-31 | $0.47 B | -2.48% |
2017-12-31 | $0.49 B | -50.78% |
2016-12-31 | $0.99 B | -19.19% |
2015-12-31 | $1.23 B | 448.12% |
2014-12-31 | $0.22 B | -22.59% |
2013-12-31 | $0.29 B | -16.76% |
2012-12-31 | $0.34 B | -6.69% |
2011-12-31 | $0.37 B | -45.73% |
2010-12-31 | $0.69 B | 69.37% |
2009-12-31 | $0.40 B | -31.92% |
2008-12-31 | $0.59 B | 4.14% |
2007-12-31 | $0.57 B | |
2007-03-31 | $1.42 B | 175.33% |
2006-03-31 | $0.51 B | -35.88% |
2005-03-31 | $0.80 B | 15.95% |
2004-03-31 | $0.69 B | 1.47% |
2003-03-31 | $0.68 B | 11.3% |
2002-03-31 | $0.61 B | 116.59% |
2001-03-31 | $0.28 B |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | $95.88 M | -91.90% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | $25.24 M | -97.87% | ๐บ๐ธ USA |